Our Advisors
A measure of the quality of a new venture is not only the people who make up the company itself but those who believe in the venture strongly enough to donate their time and expertise to help. Our Board of Directors and Board of Scientific Advisors are leaders in the field of infectious disease and vaccine development including a Nobel Laureate, the inventor of the measles vaccine, directors of several medical institutes and centers, members of the National Academy of Sciences, past and present members of the FDA’s Vaccines and Related Biological Products Advisory Committee, and Chief Scientific Officers from several successful vaccine companies. We are very grateful to the individuals below for committing to our advisory boards, their support of the Global Vaccines concept, and their continuing guidance.
Scientific Advisors
Peter C. Doherty, Ph.D. F.R.S.
Professor of Microbiology and Immunology, University of Melbourne,
Australia; 2nd Michael F. Tamer Chair of Biomedical Research, St. Judes
Children’s Research Hospital, Memphis TN; Nobel Laureate in Physiology
or Medicine, 1996 (with Rolf M. Zinkernagel)
Mary Estes, Ph.D.
Director, Texas Gulf Coast Digestive Diseases Center; Professor of Molecular Virology and Microbiology and of Medicine, Baylor College of Medicine; Former Member, Vaccines and Related Biological Products Advisory Committee, FDA; Past President, American Society for Virology
Harry B. Greenberg, M.D.
Joseph D. Grant Professor of Medicine and Microbiology and Immunology and the Senior Associate Dean for Research and Training, Stanford University. Dr. Greenberg has over 30 years of experience in the fields of virology, immunology, and vaccine development. During a two year leave of absence from Stanford he was the Chief Scientific officer at Aviron (later acquired by MedImmune) where he played a key role in bringing the live attenuated influenza vaccine to licensure
Samuel L. Katz, M.D.
Inventor of the measles vaccine; Wilburt C. Davison Professor Emeritus of Pediatric Infectious Diseases, Duke University Medical Center; Chairman, Board of Trustees, International Vaccine Institute, Seoul, Korea; Liaison Member, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention; Co Chairman, National Network for Immunization Information; Former Member, Vaccines and Related Biological Products Advisory Committee, FDA
Thomas Monath, M.D.
Partner, Pandemic & Biodefense Fund, Kleiner Perkins Caufield & Byers; 2002 Walter Reed Medalist,; President Elect, American Society for Tropical Medicine and Hygiene; Adjunct Professor, Harvard School of Public Health
Peter Palese, Ph.D.
Professor and Chair of the Department of Microbiology, Mount Sinai School of Medicine, New York; Member, Vaccines and Related Biological Products Advisory Committee, FDA; Member, National Academy of Sciences; Co-Founder of Aviron, Inc. (later acquired by MedImmune); President-elect of the American Society for Virology
Barbara Sherry, Ph.D.
Professor of Virology, Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University
Catherine Wilfert, M.D.
Scientific Director, Program for Prevention of Mother to Child Transmission, Elizabeth Glaser Pediatric AIDS Foundation; Professor Emerita of Pediatric Infectious Diseases and Microbiology, Duke University Medical Center
Business Advisors
W. William Dunn, Jr
2004-present, Chief Financial Officer and Vice President of Administrative Services at the Planned Parenthood Foundation of America in Atlanta. 1969-2000, Wachovia Bank in positions including Senior Vice President, International Operations, and Manager of Trade Finance, Global Services Division; 2000-present, Director, Trade Finance, Export Financial Services, Inc
Robert M. Price
Chairman, President and CEO, Control Data Corporation (Retired); President, PSV, Inc.; Chairman, International Multifoods Corp. (Retired); Founder and Chairman, National Center for Social Entrepreneurship; Senior Advisor, Fuqua School of Business, Duke University
Burton Weiss
1954-1976, A. G. Becker, investment banking and securities brokerage; 1976-1983, Vice-President and Director, Warburg Investment Management and Senior Director, S. G. Warburg and Co. (London); 1983-1988, consultant and Director of a number of mutual funds.
Unfortunately, Mr. Weiss passed away in 2007, but we continue to credit him here for his many important contributions to GVI.
